Current Match Time:
A diagnosis of Asherman's syndrome or uterine scarring does not mean your path to biological parenthood is over, even if previous embryo transfers have failed.
Navigating intrauterine adhesions and thin endometrial linings can feel emotionally and financially draining after investing heavily in fertility treatments.
While severe scar tissue can impair how the uterus functions, egg quality and embryo development are controlled separately by the ovaries.
You can request free surrogacy information today to learn how pairing your existing embryos with a pre-screened gestational carrier helps protect your family-building investment.
How Does Asherman's Syndrome Affect IVF?
Asherman's syndrome involves the formation of intrauterine adhesions, or bands of fibrous scar tissue, inside the uterine cavity.
These adhesions typically develop after uterine surgeries, such as dilation and curettage (D&C), infection, or operative complications, causing opposing uterine walls to stick together.
Scar tissue alters the physical structure of the uterine cavity, diminishes blood supply to the tissue, and prevents the endometrial lining from growing to an adequate thickness for implantation.
While IVF successfully combines eggs and sperm in a lab to form healthy blastocysts, it cannot overcome severe physical barriers within the uterine cavity.
Ovarian function and egg quality remain completely separate from uterine factors, meaning intended parents can often create genetically related embryos even if carrying a pregnancy is not medically possible.
Prospective parents can review guidelines on reproductive health to learn how uterine conditions are evaluated during fertility care.
How Severity of Asherman's Syndrome Changes IVF Outcomes
Reproductive specialists classify Asherman's syndrome as mild, moderate, or severe based on the extent of scar tissue present and how much of the uterine cavity is occluded.
Mild cases feature thin, film-like adhesions that leave most of the cavity open, resulting in higher pregnancy success rates after treatment.
Moderate to severe cases involve dense, thick bands of fibrotic tissue that block the tubal ostia or completely obliterate the uterine cavity.
Severe scarring significantly lowers embryo implantation rates and increases the risk of early pregnancy loss, placenta accreta, and third-trimester obstetric complications.
Hysteroscopic Scar Removal for Asherman’s Syndrome
Hysteroscopic adhesiolysis is the primary surgical treatment for uterine scarring, performed by inserting a thin scope through the cervix to cut and remove scar tissue under direct visualization.
Surgeons use micro-scissors or specialized tools rather than electric cautery to minimize thermal injury to the surrounding delicate endometrium.
The goal of hysteroscopic surgery is to restore normal cavity anatomy and encourage the remaining healthy endometrial tissue to regenerate.
Intended parents can examine frozen embryo transfer success data to understand how uterine cavity health impacts transfer outcomes.
Can Asherman's Syndrome Return After Surgery?
Intrauterine adhesions have a high rate of recurrence, particularly in severe cases where extensive surgical dissection is required.
To prevent reforming scar tissue, specialists frequently insert an intrauterine balloon catheter or heart-shaped stent for several days post-surgery.
High-dose oral estrogen therapy is prescribed for several weeks following adhesiolysis to stimulate rapid endometrial growth over raw uterine surfaces.
Follow-up diagnostic hysteroscopy or saline-infusion sonography is routinely scheduled four to eight weeks later to confirm the cavity remains open.
Repeated surgical interventions can yield diminishing returns if the basal layer of the endometrium has been permanently destroyed by fibrotic changes.
IVF Protocols for Asherman’s Syndrome
Fertility clinics modify standard transfer protocols to encourage endometrial proliferation and maximize blood flow to damaged uterine tissue.
Customized clinical protocols for uterine scarring frequently include:
- Post-Surgical Healing Protocols: Utilizing extended high-dose estrogen therapy alongside antiplatelet medications to promote tissue regrowth following hysteroscopy.
- Extended Medicated FET Cycles: Extending the estrogen preparation phase prior to adding progesterone to give a thin endometrial lining extra time to grow.
- Stimulated or Semi-Natural FET Protocols: Using low-dose gonadotropins or letrozole to induce natural ovulation and leverage endogenous estrogen production.
- Vasodilator Therapies: Administering oral sildenafil, pentoxifylline, or vitamin E to enhance pelvic circulation and support uterine blood flow.
- Intrauterine PRP Therapy: Instilling autologous platelet-rich plasma directly into the uterine cavity to stimulate local growth factors and endometrial cell proliferation.
What Should You Do After IVF Failure Caused by Uterine Scarring?
Facing an unsuccessful transfer or recurrent implantation loss when dealing with uterine scarring requires a clear, structured review of your medical options.
It is completely natural to feel exhausted by repeated medical procedures, surgeries, and hormonal cycles that do not result in a healthy pregnancy.
- Perform Diagnostic Re-Evaluation: Schedule a repeat diagnostic hysteroscopy or 3D saline sonogram to determine whether adhesions have reformed or if the lining remains severely damaged.
- Evaluate Embryo Quality and Inventory: Review preimplantation genetic testing results and assess how many healthy, chromosomally normal blastocysts remain in storage.
- Consult Your Care Team: Discuss whether adjusting medication protocols offers a realistic statistical chance of success or if surgical limits have been reached.
- Explore Alternative Paths: Evaluate gestational surrogacy as a parallel option to protect remaining embryos while avoiding further physical and emotional strain.
You can read more about understanding why IVF fails to learn how post-failure evaluations help guide your next steps.
When Should You Consider Surrogacy?
Gestational surrogacy becomes a clear, medically sound option when the uterus cannot safely support implantation or carry a pregnancy to full term.
Reproductive endocrinologists often recommend moving to a gestational carrier under specific clinical conditions:
- Multiple Unsuccessful Transfers: Experiencing repeated transfer failures using chromosomally normal, high-quality embryos.
- Refractory Thin Endometrium: Chronic inability to achieve an endometrial thickness above 6 mm despite aggressive hormonal and vasodilator therapies.
- Recurrent Adhesion Formation: Rapid reformation of dense intrauterine scar tissue following multiple surgical procedures.
- Elevated Obstetric Risks: Severe uterine distortion that increases the risk of uterine rupture, placenta accreta, or life-threatening hemorrhage.
- Limited Embryo Inventory: Possessing a finite number of frozen blastocysts where transferring into a pre-screened carrier provides the highest probability of success.
Intended parents can compare surrogacy embryo transfer success statistics to weigh personal pregnancy attempts against carrier transfer rates.
How Surrogacy Can Help After IVF Fails Due to Asherman's Syndrome
Surrogacy separates embryo creation from gestation, giving intended parents a proven path to parenthood without uterine factor limitations.
Parents who already have frozen blastocysts from previous IVF cycles can easily transfer those embryos to a gestational surrogate's care.
You can review details on the surrogacy medical process overview to understand how clinical care transitions smoothly to your surrogate.
Gestational carriers undergo comprehensive medical history reviews, physical exams, and psychological screening based on guidelines established by medical boards.
Candidates must have a proven history of at least one uncomplicated, full-term pregnancy and pass rigorous uterine evaluations conducted by your fertility clinic.
Choosing a Surrogacy Agency after IVF Failure
Transitioning from repeated fertility treatments to gestational surrogacy restores momentum and peace of mind to your family-building plans.
American Surrogacy supports intended parents through pre-screened candidate matching, clear timeline management, and robust financial safeguards.
Key agency advantages include:
- Efficient Matching Speed: Broad national recruitment maintains a balanced waiting list, supporting an average match timeline of 1–6 months.
- Comprehensive Pre-Screening: Every surrogate completes medical history reviews, background checks, and psychological evaluations prior to matching.
- Financial Protection Safeguards: Our Limited Risk Program provides unlimited rematching without repeating agency match fees if an unexpected setback occurs.
You can request free surrogacy information today to discover how agency financial protections help safeguard your investment.
Talk to American Surrogacy About Your Next Step
Navigating family-building choices after an IVF failure requires objective medical facts, transparent guidance, and a supportive team dedicated to your goals.
American Surrogacy helps you evaluate your family-building options, review financial protection models, and transition smoothly toward parenthood.
You can request free surrogacy information today to connect with a surrogacy specialist and begin planning your next steps.